Fairfield Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-85
Closed -$6.79K – 140
2024
Q4
$6.79K Sell
85
-50
-37% -$4.33K ﹤0.01% 215
2024
Q3
$12.2K Hold
135
– – ﹤0.01% 215
2024
Q2
$10.6K Buy
+135
New +$11.1K ﹤0.01% 210
2023
Q4
$11.1K Sell
135
-5
-4% -$381 ﹤0.01% 230
2023
Q3
$11K Hold
140
– – ﹤0.01% 215
2023
Q2
$12.3K Hold
140
– – ﹤0.01% 223
2023
Q1
$11.1K Hold
140
– – ﹤0.01% 233
2022
Q4
$10.9K Hold
140
– – 0.01% 212
2022
Q3
$11.3K Hold
140
– – 0.01% 205
2022
Q2
$12.6K Hold
140
– – 0.01% 185
2022
Q1
$15.5K Buy
+140
New +$14.8K 0.01% 195

Other funds holding MDT

Fairfield Financial Advisors's MDT Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Medtronic (MDT) in Q1 2025, closing a stake of 85 shares — an estimated $6.79K sold.

Fairfield Financial Advisors first reported a position in MDT in Q1 2022 and held it in 11 quarters. The position peaked at $15.5K in Q1 2022. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 85 Medtronic shares in Q1 2025, an estimated $6.79K.
  • Fairfield Financial Advisors first reported a position in Medtronic in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's Medtronic position peaked at $15.5K in Q1 2022.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.